Correlation between changes in bodyweight and changes in ascites volume in liver cirrhosis patients with hepatic edema in short-term diuretic therapy
Author:
Affiliation:
1. Yamaguchi University Graduate School of Medicine; Ube
2. Social Insurance Alliance Shimonoseki Kosei Hospital; Shimonoseki Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12171/fullpdf
Reference26 articles.
1. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites;El-Bokl;World J Gastroenterol,2009
2. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club;Moore;Hepatology,2003
3. Management of ascites in cirrhosis;Wong;J Gastroenterol Hepatol,2012
4. Ascites: pathogenesis and therapeutic principles;Møller;Scand J Gastroenterol,2009
5. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites;Sersté;J Hepatol,2012
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial;BMC Gastroenterology;2020-11-19
2. Effect of pre‐transplant sarcopenia on the estimation of standard liver volume in living‐donor liver transplant candidates: risk factor for post‐transplant small‐for‐size syndrome? A retrospective study;Transplant International;2020-08-05
3. Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study);Journal of Gastroenterology;2020-05-09
4. Treatment of Refractory Ascites;Clinical Investigation of Portal Hypertension;2019
5. Necessity of continuous tolvaptan administration based on the results of a placebo-control trial: A post-hoc analysis based on the pivotal Phase 3 trial;Kanzo;2018-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3